General Information of Drug (ID: DMBQ87R)

Drug Name
TAK-044 Drug Info
Synonyms
TAK 044; 2-[(2R,5S,8S,11S,14S,17R)-8-(carboxymethyl)-17-(1H-indol-3-ylmethyl)-14-(2-methylpropyl)-3,6,9,12,15,18-hexaoxo-5-[2-oxo-2-(4-phenylpiperidin-1-yl)ethyl]-11-thiophen-2-yl-1,4,7,10,13,16-hexazacyclooctadec-2-yl]acetic acid; AC1NSKOX; TAK044
Indication
Disease Entry ICD 11 Status REF
Renal failure GB60-GB6Z Discontinued in Phase 2 [1]
Cross-matching ID
PubChem CID
123882
CAS Number
CAS 157380-72-8
TTD Drug ID
DMBQ87R

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Discontinued Drug(s)
Drug(s) Targeting Endothelin receptor (EDNR)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Clazosentan DMQSBX4 Cerebral vasospasm BA85.Z Phase 3 [3]
Aprocitentan DMEJICQ Hypertension BA00-BA04 Phase 2 [3]
Ro-46-2005 DMRT6FV Hypertension BA00-BA04 Terminated [4]

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Endothelin receptor (EDNR) TTCV6O0 NOUNIPROTAC Modulator [2]

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 3913).
2 Pharmacology of a non-selective ETA and ETB receptor antagonist, TAK-044 and the inhibition of myocardial infarct size in rats. Br J Pharmacol. 1995 Mar;114(5):949-54.
3 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
4 In vitro characterization of Ro 46-2005, a novel synthetic non-peptide endothelin antagonist of ETA and ETB receptors. FEBS Lett. 1993 Nov 15;334(2):210-4.